Credit Agricole S A Catalent, Inc. Transaction History

Credit Agricole S A

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Nov 14, 2024	BUY	$56.16 - $60.96 $1.12 Million - $1.22 Million	19,978 Added 143.98%	33,854 $2.05 Million
Q2 2024 Aug 13, 2024	BUY	$53.58 - $57.02 $155,167 - $165,129	2,896 Added 26.38%	13,876 $780,000
Q1 2024 May 14, 2024	BUY	$42.56 - $59.82 $250,252 - $351,741	5,880 Added 115.29%	10,980 $619,000
Q4 2023 Feb 13, 2024	BUY	$32.18 - $46.57 $109,540 - $158,524	3,404 Added 200.71%	5,100 $229,000
Q3 2023 Nov 14, 2023	BUY	$44.2 - $50.2 $74,963 - $85,139	1,696 New	1,696 $77,000
Q4 2017 Feb 13, 2018	SELL	$37.27 - $43.02 $88,628 - $102,301	-2,378 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	2,378	2,378 $83,000

16.8M

10.7K

53.4K

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Credit Agricole S A, based on Form 13F filings with the SEC.

Stay updated on Credit Agricole S A with notifications on news.